Metabolic syndrome may increase prostate cancer risk

07/5/2013 | Renal and Urology News

Men with three or more metabolic syndrome components were 38% more likely than those with no risk factors to be diagnosed with prostate cancer and had a 52% higher risk of clinically significant prostate cancer and a 43% higher risk of high-grade prostate cancer, a Canadian study showed. The findings were presented at the Canadian Urological Association's 2013 meeting.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park